These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2543344)

  • 1. [Experimental study of the antibacterial activity and chemotherapeutic efficacy of the novel glycopeptide eremomycin].
    Malikova IV
    Antibiot Khimioter; 1989 Jan; 34(1):52-6. PubMed ID: 2543344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Eremomycin--a new antibiotic of the polycyclic glycopeptide group].
    Gauze GF; Brazhnikova MG; Lomakina NN; Gol'dberg LE; Laĭko AV
    Antibiot Khimioter; 1989 May; 34(5):348-52. PubMed ID: 2742419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic Gram-positive bacteria].
    Malkova IV; Borisova OK; Pavlova MV; Zemlianitskaia EP; Sergeeva TI
    Antibiot Khimioter; 1991 Apr; 36(4):17-20. PubMed ID: 1654046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties.
    Olsufyeva EN; Shchekotikhin AE; Bychkova EN; Pereverzeva ER; Treshalin ID; Mirchink EP; Isakova EB; Chernobrovkin MG; Kozlov RS; Dekhnich AV; Preobrazhenskaya MN
    Drug Des Devel Ther; 2018; 12():2875-2885. PubMed ID: 30237697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the therapeutic effect of the glycopeptide antibiotics eremomycin, vancomycin and ristomycin in a model of antibiotic-associated colitis in golden hamsters].
    Rukhlina AA
    Antibiot Khimioter; 1992 Nov; 37(11):32-5. PubMed ID: 1338681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
    J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of dimerization of polysynthetic derivatives of the antibiotic eremomycin by ESI MS and its role in elucidating antibacterial activity].
    Mirgorodskaia OA; Olsuf'eva EN; Kolume DE; Joergensen TJ; Roepstorff P; Pavlov AIu; Miroshnikova OV; Preobrazhenskaia MN
    Bioorg Khim; 2000 Aug; 26(8):631-40. PubMed ID: 11041003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycopeptide antibiotics: eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity].
    Filippos'iants ST; Malkova IV; Gol'dberg LE
    Antibiot Khimioter; 1989 Jul; 34(7):523-6. PubMed ID: 2530944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
    Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eremomycin--a new antibiotic from the cyclic glycopeptide group].
    Gauze GF; Brazhnikova MG; Laĭko AV; Sveshnikova MA; Preobrazhenskaia TP
    Antibiot Med Biotekhnol; 1987 Aug; 32(8):571-6. PubMed ID: 3674837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on chemotherapeutic efficacy, acute toxic action and nephrotoxicity of combinations of eremomycin with tobramycin].
    Shepelevtseva NG; Vinogradova IV; Shevniuk LA
    Antibiot Khimioter; 1990 Nov; 35(11):21-4. PubMed ID: 2092632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal.
    Pavlov AY; Berdnikova TF; Olsufyeva EN; Lazhko EI; Malkova IV; Preobrazhenskaya MN; Testa RT; Petersen PJ
    J Antibiot (Tokyo); 1993 Nov; 46(11):1731-9. PubMed ID: 8270496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455.
    Yarlagadda V; Konai MM; Manjunath GB; Prakash RG; Mani B; Paramanandham K; Ranjan SB; Ravikumar R; Chakraborty SP; Roy S; Haldar J
    Int J Antimicrob Agents; 2015 Jun; 45(6):627-34. PubMed ID: 25900818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
    Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
    J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preclinical toxicological study of the new antibiotic eremomycin. Its acute toxicity for laboratory animals].
    Gol'dberg LE; Stepanova ES; Vertogradova TP; Shevniuk LA; Shepelevtseva NG
    Antibiot Med Biotekhnol; 1987 Dec; 32(12):910-5. PubMed ID: 2830839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of glycopeptide antibiotic eremomycin by the action of alkyl halides and study on antibacterial activity of the compounds obtained.
    Pavlov AY; Olsufyeva EN; Berdnikova TF; Malkova IV; Preobrazhenskaya MN; Risbridger GD
    J Antibiot (Tokyo); 1994 Feb; 47(2):225-32. PubMed ID: 8150719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity].
    Pavlov AIu; Olsuf'eva EN; Miroshnikova OV; Reznikova MI; Lazhko EI; Malabarba A; Ciabatti R; Preobrazhenskaia MN
    Bioorg Khim; 1997 May; 23(5):410-21. PubMed ID: 9290051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oritavancin: a new avenue for resistant Gram-positive bacteria.
    Mercier RC; Hrebickova L
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):325-32. PubMed ID: 15954849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.